Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer

Código QR

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer

Qiumo Zhang,1,* Haiyang Zhang,1,* Tao Ning,1 Dongying Liu,1 Ting Deng,1 Rui Liu,1 Ming Bai,1 Kegan Zhu,1 Jialu Li,2 Qian Fan,1 Guoguang Ying,1 Yi Ba1 1Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Thera...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhang Q, Zhang H, Ning T, Liu D, Deng T, Liu R, Bai M, Zhu K, Li J, Fan Q, Ying G, Ba Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	exosomes；c-met sirna chemoresistance gastric cancer Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/daf083d9d7c64749aeaa956e9a67a257
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
por: Dan Lin, et al.
Publicado: (2021)

A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis
por: Yongzhi Cui, et al.
Publicado: (2022)

Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
por: Ma Y, et al.
Publicado: (2019)

Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy
por: Yang Z, et al.
Publicado: (2018)

Exosomal-mediated transfer of OIP5-AS1 enhanced cell chemoresistance to trastuzumab in breast cancer via up-regulating HMGB3 by sponging miR-381-3p
por: Yu Qiang, et al.
Publicado: (2021)

Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development
por: Kok VC, et al.
Publicado: (2020)

CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging
por: Zhang T, et al.
Publicado: (2021)

c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer
por: Chung Hyo Kang, et al.
Publicado: (2021)

Effects of Cynaroside on Cell Proliferation, Apoptosis, Migration and Invasion though the MET/AKT/mTOR Axis in Gastric Cancer
por: Juanli Ji, et al.
Publicado: (2021)

A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells
por: Yao H, et al.
Publicado: (2020)

Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression
por: Zhefeng Li, et al.
Publicado: (2018)

Targeting HGF/c-Met Axis Decreases Circulating Regulatory T Cells Accumulation in Gastric Cancer Patients
por: Juliette Palle, et al.
Publicado: (2021)

Orthogonal MET analysis in a population‐representative stage II–III colon cancer cohort: prognostic and potential therapeutic implications
por: Stephanie G. Craig, et al.
Publicado: (2021)

Exosomal microRNA-107 reverses chemotherapeutic drug resistance of gastric cancer cells through HMGA2/mTOR/P-gp pathway
por: Lu Jiang, et al.
Publicado: (2021)

Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles
por: Chen Z, et al.
Publicado: (2018)

Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner
por: Qin X, et al.
Publicado: (2017)

Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides
por: Maria Carmina Scala, et al.
Publicado: (2021)

Research Progress on CircRNA in Liquid Biopsy of Gastric Cancer
por: ZHU Hao, et al.
Publicado: (2021)

VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer
por: Chen J, et al.
Publicado: (2017)

Palmatine sensitizes chemoresistant triple negative breast cancer cells via efflux inhibition of multidrug resistant protein 1.
por: Selase Ativui, et al.
Publicado: (2021)

Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
por: Javad Khanali, et al.
Publicado: (2021)

Exosomes as Actively Targeted Nanocarriers for Cancer Therapy
por: Wang Y, et al.
Publicado: (2020)

Exosomes: mediators of communication in eukaryotes
por: Lopez-Verrilli,María A, et al.
Publicado: (2013)

Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7
por: Bi YZ, et al.
Publicado: (2016)

Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes
por: Hemati M, et al.
Publicado: (2019)

Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia
por: Mingyue Shi, et al.
Publicado: (2021)

In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice
por: Shi Q, et al.
Publicado: (2018)

The therapeutic effect in gliomas of nanobubbles carrying siRNA combined with ultrasound-targeted destruction
por: Cai W, et al.
Publicado: (2018)

Corosolic acid reduces A549 and PC9 cell proliferation, invasion, and chemoresistance in NSCLC via inducing mitochondrial and liposomal oxidative stress
por: Mingming Jin, et al.
Publicado: (2021)

Comprehensive comparison of MetAP2 tissue and cellular expression pattern in lean and obese rodents
por: Han J, et al.
Publicado: (2018)

Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes
por: Jin M, et al.
Publicado: (2018)

Engineering Exosome-Like Nanovesicles Derived from Asparagus cochinchinensis Can Inhibit the Proliferation of Hepatocellular Carcinoma Cells with Better Safety Profile
por: Zhang L, et al.
Publicado: (2021)

Decoy exosomes as a novel biologic reagent to antagonize inflammation
por: Duong N, et al.
Publicado: (2019)

High-intensity focused ultrasound ablation as an adjuvant surgical salvage procedure in gestational trophoblastic neoplasia chemotherapy with chemoresistance or recurrence: two case reports
por: Chaokun She, et al.
Publicado: (2021)

Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions
por: Ortega RA, et al.
Publicado: (2016)

MET Amplification and Efficacy of Nivolumab in Patients With NSCLC
por: Katsuhiro Yoshimura, MD, PhD, et al.
Publicado: (2021)

Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy
por: Wang C, et al.
Publicado: (2020)

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors
por: Lun-Xi Peng, et al.
Publicado: (2021)

Galvus and Galvus Met, new registered medicinal agents for the treatment of diabetes mellitus
por: Editorial team Diabetes Mellitus
Publicado: (2009)

Case Report: Sequential Combination Targeted Therapy With Type I and II MET Inhibitors in a Metastatic EGFR-Mutated, MET-Amplified NSCLC Patient With Acquired MET Y1230H Mutation
por: Boning Cai, et al.
Publicado: (2021)